Published in Clin Exp Immunol on December 01, 1980
Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor. Infect Immun (1982) 1.79
Lymphocyte traffic and lymphocyte destruction in murine malaria. Immunology (1982) 1.13
Differential involvement of non-specific suppressor T cells in two lethal murine malaria infections. Clin Exp Immunol (1981) 1.11
T-independent macrophage changes in murine malaria. Clin Exp Immunol (1983) 0.90
Macrophage-lymphocyte interaction in response to a bacterial antigen (E. coli). Clin Exp Immunol (1982) 0.86
Synergistic effects of locally administered cytostatic drugs and a surfactant on the development of delayed-type hypersensitivity to keyhole limpet haemocyanin in mice. Clin Exp Immunol (1989) 0.82
Modulation of primary antibody responses to sheep erythrocytes in Plasmodium chabaudi-infected resistant and susceptible mouse strains. Infect Immun (1986) 0.81
Rapid parasite multiplication rate, rather than immunosuppression, causes the death of mice infected with virulent Plasmodium yoelii. Infect Immun (1987) 0.78
Probable macrophage origin of the lipopolysaccharide-induced cytostatic effect on intra-erythrocytic malarial parasites (Plasmodium vinckei). Immunology (1982) 0.75
Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology (1968) 24.83
Is azathioprine a better immunosuppressive than 6-mercaptopurine? Clin Exp Immunol (1971) 3.47
Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet (1974) 2.83
Impairment of the immune response to vaccination after acute malaria. Lancet (1978) 2.39
T-cell activation in murine malaria. Nature (1975) 2.23
Subclasses of T cells with different sensitivities to cytotoxic antibody in the presence of anesthetics. Eur J Immunol (1975) 1.94
A splenic requirement for the generation of suppressor T cells. J Immunol (1977) 1.86
Autoimmune and polyclonal B cell responses during murine malaria. Nature (1978) 1.83
Cell-mediated immunity in mice vaccinated against malaria. Clin Exp Immunol (1978) 1.82
Cell-mediated immunity in the liver of mice vaccinated against malaria. Nature (1979) 1.64
Depression of delayed-type hypersensitivity by Corynebacterium parvum: mandatory role of the spleen. Cell Immunol (1974) 1.58
Contact sensitivity to picryl chloride: the occurrence of B suppressor cells in the lymph nodes and spleen of immunized mice. Cell Immunol (1976) 1.54
Malarial immunodepression in vitro: adherent spleen cells are functionally defective as accessory cells in the response to horse erythrocytes. Eur J Immunol (1976) 1.47
Immunity to Plasmodium berghei yoelii in mice. II. Specific and nonspecific cellular and humoral responses during the course of infection. J Immunol (1978) 1.32
Influence of malaria infection on the elaboration of soluble mediators by adherent mononuclear cells. Infect Immun (1979) 1.27
Cyclophosphamide pretreatment and protection against malaria. Infect Immun (1976) 1.25
The reactivity of spleen cells from malarious rats to non-specific mitogens. Clin Exp Immunol (1976) 1.20
Prostaglandin synthesis in spleen cell cultures of mice injected with Corynebacterium parvum. Cell Immunol (1978) 1.20
Dissociative effects of malarial infection on humoral and cell-mediated immunity in mice. Immunology (1979) 1.10
Regional immunosuppression induced by Plasmodium berghei yoelii infection in mice. Infect Immun (1975) 1.09
Modulation by malaria infection of the induction of T lymphocyte-dependent delayed-type hypersensitivity and antibody formation to sheep erythrocytes in mice. Parasite Immunol (1979) 0.90
A mechanism for the depression of contact sensitivity with B-cell mitogens. Ann Immunol (Paris) (1980) 0.89
The cellular basis of immunological responses. A synthesis of some current views. Lancet (1969) 6.05
Focal antibody production by transferred spleen cells in irradiated mice. Science (1965) 3.12
Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol (1989) 3.09
Strain differences in the immune response of mice. I. The neonatal response to sheep red cells. Immunology (1968) 2.98
Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56
Malarial parasites induce TNF production by macrophages. Immunology (1988) 2.42
Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34
Endotoxin-induced serum factor kills malarial parasites in vitro. Infect Immun (1981) 2.30
Induction of red cell autoantibodies in normal mice. Nat New Biol (1973) 2.09
Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis. Eur J Immunol (1989) 2.04
Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei. Immunology (1977) 2.03
Immunosuppressive potency and in-vitro activity of antilymphocyte globulin. Lancet (1969) 2.02
Cell cooperation in the immune response. Clin Exp Immunol (1971) 1.91
Cell-mediated immunity in mice vaccinated against malaria. Clin Exp Immunol (1978) 1.82
Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor. Infect Immun (1982) 1.79
Suppressor T cells in experimental autoimmune haemolytic anaemia. Nature (1978) 1.79
Separate thymus dependent and thymus independent antibody forming cell precursors. Nat New Biol (1971) 1.78
Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid. Immunology (1992) 1.78
Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. Immunology (1989) 1.77
Killing of human malaria parasites by macrophage secretory products. Infect Immun (1984) 1.76
Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria. Infect Immun (1997) 1.75
Killing of blood-stage murine malaria parasites by hydrogen peroxide. Infect Immun (1983) 1.74
The role of antibody in T-cell responses. Clin Exp Immunol (1974) 1.67
The role of the liver in immunity to blood-stage murine malaria. Immunology (1980) 1.65
Cell-mediated immunity in the liver of mice vaccinated against malaria. Nature (1979) 1.64
Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clin Exp Immunol (1987) 1.62
Rosette formation by mouse lymphocytes. III. Receptors for immunoglobulin on normal and activated T cells. Clin Exp Immunol (1974) 1.59
Strain differences in the immune responses of mice. 3. A raised tolerance threshold in NZB thymus cells. Immunology (1971) 1.57
Specific tolerance to sheep erythrocytes in mouse bone marrow cells. Nature (1969) 1.52
Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector. EMBO J (1987) 1.48
Response of mouse T and B lymphocytes to sheep erythrocytes. Nat New Biol (1972) 1.45
Strain differences in the immune response of mice. II. Responses by neonatal cells in irradiated adult hosts. Immunology (1968) 1.45
Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice. Clin Exp Immunol (1987) 1.42
Response to phytohaemagglutinin of lymphocytes from mice treated with anti-lymphocyte globulin. Immunology (1969) 1.41
Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum. Parasite Immunol (1990) 1.40
Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer (1994) 1.39
Rosette formation by mouse lymphocytes. II. T-cell specificities in a CRL subpopulation. Clin Exp Immunol (1974) 1.39
Role of complement in immune lysis of Trypanosoma cruzi. Infect Immun (1972) 1.38
Indirect immunofluorescence of mouse thymus-derived cells using heterologous anti-brain serum. Cell Immunol (1973) 1.38
Reactivity and crossreactivity of mouse helper T cells to malaria parasites. Immunology (1977) 1.36
Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF. Immunology (1990) 1.35
Killing of the malarial parasite Plasmodium yoelii in vitro by cells of myeloid origin. Parasite Immunol (1982) 1.34
Antibody responses in mice protected against malaria by vaccination. Parasite Immunol (1979) 1.34
Immunity to malaria. Br Med Bull (1982) 1.34
Antibody formation by bone marrow cells in irradiated mice. I. Thymus-dependent and thymus-independent responses to sheep erythrocytes. Immunology (1971) 1.31
Syngeneic splenomegaly in NZB and BALB-c mice. Transplantation (1969) 1.30
Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice. Clin Exp Immunol (1974) 1.27
The genetic basis of autoimmunity in NZB mice studied by progeny-testing. Clin Exp Immunol (1971) 1.24
Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology (1992) 1.23
Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages. Infect Immun (1990) 1.21
Vaccination of mice against malaria with soluble antigens. I. The effect of detergent, route of injection, and adjuvant. Parasite Immunol (1986) 1.20
Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology (1994) 1.19
Rosette formation by mouse lymphocytes. I. Demonstration by indirect immunofluorescence of T cells binding sheep erythrocytes. Clin Exp Immunol (1974) 1.17
Immunoglobulin studies in serum of patients with American trypanosomiasis (Chagas' disease). Clin Exp Immunol (1970) 1.17
Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature (1983) 1.15
Stimulation and suppression of response of mouse T cells to the schistosomules of Schistosoma mansoni during infection. Nature (1976) 1.14
Serum IL-2 inhibitor in mice. I. Increase during infection. Immunology (1985) 1.14
Age-dependent changes in the relative affinity of anti-dinitrophenyl antibodies in mice. Immunology (1975) 1.13
B cells: subpopulations, tolerance, autoimmunity, and infection. Immunol Rev (1979) 1.13
Lymphocyte traffic and lymphocyte destruction in murine malaria. Immunology (1982) 1.13
Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity. Clin Exp Immunol (1985) 1.12
Macrophage cytotoxicity in lethal and non-lethal murine malaria and the effect of vaccination. Clin Exp Immunol (1986) 1.12
Differential involvement of non-specific suppressor T cells in two lethal murine malaria infections. Clin Exp Immunol (1981) 1.11
Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens. Infect Immun (1992) 1.10
Killing of Plasmodium yoelii by enzyme-induced products of the oxidative burst. Infect Immun (1984) 1.10
Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody. Immunol Lett (1990) 1.09
Macrophages as effector cells in immunity to malaria. Immunol Lett (1985) 1.09
Changes in the capacity of macrophages and T cells to produce interleukins during murine malaria infection. Cell Immunol (1984) 1.06
Endotoxin induced 'tumour-necrosis serum' kills a subpopulation of normal lymphocytes in vitro. Clin Exp Immunol (1982) 1.05
Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization. J Immunol (1989) 1.05
Anti-lymphocyte antibodies in lethal mouse malaria. II. Induction of an autoantibody specific suppressor T cell by non-lethal P. yoelii. Clin Exp Immunol (1983) 1.04
Cooperation by mouse T lymphocytes: the role of antibody in T cell specificity. Eur J Immunol (1974) 1.03
Failure of malaria vaccination in mice born to immune mothers. Clin Exp Immunol (1982) 1.03
Antilymphocyte autoantibody in lethal mouse malaria and its suppression by non-lethal malaria. Parasite Immunol (1983) 1.02
Early maturation of immune responses in neonatal New Zealand black (NZB) mice. Proc R Soc Med (1967) 1.02
Hyper-responsiveness in NZB mice to the experimental induction of anti-red cell autoantibody. Clin Exp Immunol (1977) 1.02
Hypoglycemia and hyperinsulinemia in rodent models of severe malaria infection. Infect Immun (1994) 1.01
Polyclonal in vitro proliferative responses from nonimmune donors to Plasmodium falciparum malaria antigens require UCHL1+ (memory) T cells. Eur J Immunol (1990) 1.01
Killing of Plasmodium falciparum by eosinophil secretory products. Infect Immun (1987) 1.01
Serological relationship of tumor necrosis factor-inducing exoantigens of Plasmodium falciparum and Plasmodium vivax. Infect Immun (1992) 1.01
Malaria: toxins, cytokines and disease. Parasite Immunol (1995) 1.01
Studies of cellular immunity in Chagas disease: effect of glutaraldehyde-treated specific antigen on inhibition of leukocyte migration. J Immunol (1974) 1.00
Failure of malaria vaccination in mice born to immune mothers. II. Induction of specific suppressor cells by maternal IgG. Clin Exp Immunol (1983) 1.00
Cross-reactions between erythrocytes at the T-cell level. Immunology (1973) 0.99
Plasmodium yoelii and Plasmodium vinckei: the effects of nonspecific immunostimulation on murine malaria. Exp Parasitol (1977) 0.99
Malaria, Epstein-Barr virus, and the genesis of lymphomas. Adv Cancer Res (1989) 0.98
B cell-derived immunoglobulin on activated mouse T lymphocytes. Nature (1974) 0.97
Phospholipid-containing toxic malaria antigens induce hypoglycaemia. Clin Exp Immunol (1992) 0.96
Development and suppression of a population of late-adhering macrophages in mouse malaria. Parasite Immunol (1979) 0.96
Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant. Infect Immun (1996) 0.96
Serum IL-2 inhibitor in mice. II. Molecular characteristics. Immunology (1985) 0.96
Differential tolerance of thymus-independent and thymus-dependent antibody responses. Immunology (1978) 0.96
Deficient cell-mediated immunity in adult NZB mice. Transplantation (1970) 0.95
Interferon-gamma as an adjuvant in immunocompromised mice. Immunology (1989) 0.95
Rosette formation by mouse lymphocytes. IV. Fc and C3 receptors occurring together and separately on T cells and other leucocytes. Clin Exp Immunol (1975) 0.95